| Company: | McKesson Corporation |
|---|---|
| CEO: |
|
| Founded: | 1833 |
| Symbol: | MCK |
| Exchange: | NYSE |
| Industry: | Medical - Distribution |
| Sector: | Healthcare |
| About |
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas. |
23 among 2804 companies
6555 State Highway 161
Irving | TX |
US
McKesson Corporation’s revenue by segment: Medical-Surgical Solutions Segment: $11.51 B, North American Pharmaceutical Segment: $336.65 B, Oncology And Multispecialty Segment: $48.42 B, Prescription Technology Solutions Segment: $5.81 B and Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment: $1.04 B in 2026.
| McKesson Corporation;MCK;https://financialmodelingprep.com/image-stock/MCK.png;mckesson-corporation | 403430000000.00 |
|---|---|
| Cardinal Health;CAH;https://bullfincher.io/logos/us/CAH.png;cardinal-health | 222578000000.00 |
| Cencora;COR;https://bullfincher.io/company_logos_external/COR.png;cencora | 321332819000.00 |
McKesson Corporation was founded on 1833, which makes the company 193 years old.
Brian S. Tyler is the CEO of McKesson Corporation.
McKesson Corporation operates in the Medical - Distribution industry and the Healthcare sector.
McKesson Corporation has 43,000 employees.
In fiscal year 2026, McKesson Corporation generated a revenue of $403.43 Billion.
In fiscal year 2026, McKesson Corporation reported a net income of $4.76 Billion.
North American Pharmaceutical Segment is McKesson Corporation's biggest product segment, representing 83.45% of its total revenue.
McKesson Corporation went public on Nov 10, 1994, through its Initial Public Offering (IPO), and it has been 31 years since then.
McKesson Corporation's ticker symbol is MCK, and the company is listed on the NYSE stock market exchange.
McKesson Corporation's current stock price is $803.44 as of Jul 15, 2026.
Ranked #23among 2,804 companies based on market cap.
Competitors of McKesson Corporation include Cardinal Health and Cencora, and more.